TY  - GEN
AU  - Medd,P G
AU  - Peniket,A J
AU  - Littlewood,T J
AU  - Pearce,R
AU  - Perry,J
AU  - Kirkland,K E
AU  - Shaw,B E
AU  - Potter,M N
AU  - Craddock,C F
AU  - Milligan,D W
AU  - Fielding,A K
AU  - Marks,D I
AU  - Cook,G
TI  - Evidence for a GVL effect following reduced-intensity allo-SCT in ALL: a British Society of Blood and Marrow Transplantation study
SN  - 1476-5365
PY  - 2014///0204
KW  - Acute Disease
KW  - Adolescent
KW  - Adult
KW  - Age Factors
KW  - Alemtuzumab
KW  - Allografts
KW  - Antibodies, Monoclonal, Humanized
KW  - administration & dosage
KW  - Antineoplastic Agents
KW  - Disease-Free Survival
KW  - Female
KW  - Graft vs Host Disease
KW  - etiology
KW  - Graft vs Leukemia Effect
KW  - Humans
KW  - Male
KW  - Middle Aged
KW  - Precursor Cell Lymphoblastic Leukemia-Lymphoma
KW  - mortality
KW  - Sex Factors
KW  - Societies, Medical
KW  - Stem Cell Transplantation
KW  - Survival Rate
KW  - Transplantation Conditioning
KW  - United Kingdom
KW  - Vidarabine
N1  - Publication Type: Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1038/bmt.2012.261
ER  -